Literature DB >> 14720022

Comparison of intranasal corticosteroids and antihistamines in allergic rhinitis: a review of randomized, controlled trials.

Lars P Nielsen1, Ronald Dahl.   

Abstract

For several years there has been discussion of whether first-line pharmacological treatment of allergic rhinitis should be antihistamines or intranasal corticosteroids. No well documented, clinically relevant differences seem to exist for individual nonsedating antihistamines in the treatment of allergic rhinitis. Likewise, the current body of literature does not seem to favor any specific intranasal corticosteroid. When comparing efficacy of antihistamines and intranasal corticosteroids in allergic rhinitis, present data favor intranasal corticosteroids. Interestingly, data do not support antihistamines as superior in treating conjunctivitis associated with allergic rhinitis. Safety data from comparative studies in allergic rhinitis do not indicate differences between antihistamines and intranasal corticosteroids. Combining antihistamines and intranasal corticosteroids in the treatment of allergic rhinitis does not provide additional beneficial effects to intranasal corticosteroids alone. Considering present data, intranasal corticosteroids seem to offer superior relief in allergic rhinitis, when compared with antihistamines.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14720022     DOI: 10.1007/bf03256639

Source DB:  PubMed          Journal:  Am J Respir Med        ISSN: 1175-6365


  9 in total

Review 1.  The economic burden of allergic rhinitis: a critical evaluation of the literature.

Authors:  Shelby D Reed; Todd A Lee; Douglas C McCrory
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

Review 2.  The safety and efficacy of desloratadine for the management of allergic disease.

Authors:  William E Berger
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

3.  [New generation antihistamines as monotherapy or in combination. What is the relevance for daily clinical routine for allergic rhinoconjunctivitis].

Authors:  R Mösges; J Köberlein
Journal:  HNO       Date:  2007-06       Impact factor: 1.284

4.  Systemic corticosteroid monotherapy for clinically diagnosed acute rhinosinusitis: a randomized controlled trial.

Authors:  Roderick P Venekamp; Marc J M Bonten; Maroeska M Rovers; Theo J M Verheij; Alfred P E Sachs
Journal:  CMAJ       Date:  2012-08-07       Impact factor: 8.262

Review 5.  Intranasal steroids in the treatment of allergy-induced rhinorrhea.

Authors:  Robert A Nathan
Journal:  Clin Rev Allergy Immunol       Date:  2011-08       Impact factor: 8.667

Review 6.  Therapeutic targets in rhinosinusitis: infection or inflammation?

Authors:  Valerie J Lund
Journal:  Medscape J Med       Date:  2008-04-29

Review 7.  Mometasone furoate nasal spray: a systematic review.

Authors:  Desiderio Passali; Maria Carla Spinosi; Anna Crisanti; Luisa Maria Bellussi
Journal:  Multidiscip Respir Med       Date:  2016-05-02

8.  Efficacy of fluticasone furoate nasal spray and levocetirizine in patients with Japanese cedar pollinosis subjected to an artificial exposure chamber.

Authors:  Kazuhiro Hashiguchi; Sho Kanzaki; Ken-Ichiro Wakabayashi; Nobuaki Tanaka; Kayoko Kawashima; Kiyochika Suematsu; Shoji Tokunaga; Kaoru Ogawa; Kimihiro Okubo
Journal:  J Drug Assess       Date:  2013-07-26

9.  Effectiveness of twice daily azelastine nasal spray in patients with seasonal allergic rhinitis.

Authors:  Friedrich Horak
Journal:  Ther Clin Risk Manag       Date:  2008-10       Impact factor: 2.423

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.